[Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
作者信息
Seifert M, Wierrani F, Kubista E, Spona J
机构信息
I. Univers.-Frauenklinik Wien.
出版信息
Gynakol Rundsch. 1991;31 Suppl 2:397-8.
PMID:1790992
Abstract
摘要
相似文献
1
2
[Tumor markers in the diagnosis and prognosis of breast cancer].[肿瘤标志物在乳腺癌诊断和预后中的应用]
Klin Med (Mosk). 1993;71(2):25-7.
3
Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.局部区域性乳腺癌患者癌胚抗原（CEA）和糖类抗原15.3（CA 15.3）的前瞻性评估
Anticancer Res. 2003 Mar-Apr;23(2A):1035-41.
4
[Prognostic factors in breast cancer].[乳腺癌的预后因素]
Gynakologe. 1994 Feb;27(1):37-44.
5
6
7
[Tumor markers in metastatic breast carcinoma: correlations with clinical response].
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):127-30.
8
9
The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.通过连续测量肿瘤标志物早期检测播散性（转移性）乳腺癌。
Eur J Cancer Prev. 1993 Nov;2 Suppl 3:133-9.
10
Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.乳腺癌患者血清癌胚抗原、糖类抗原15-3和巨细胞动脉炎抗体的临床评估
Cancer Detect Prev. 1993;17(3):411-5.
Zotero 插件